Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Hepatitis C virus targets the T cell secretory machinery as a mechanism of immune evasion.

Petrovic D, Stamataki Z, Dempsey E, Golden-Mason L, Freeley M, Doherty D, Prichard D, Keogh C, Conroy J, Mitchell S, Volkov Y, McKeating JA, O'Farrelly C, Kelleher D, Long A.

Hepatology. 2011 Jun;53(6):1846-53. doi: 10.1002/hep.24327. Epub 2011 May 2.

PMID:
21452285
2.

CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.

Zhang S, Kodys K, Babcock GJ, Szabo G.

Hepatology. 2013 Sep;58(3):940-9. doi: 10.1002/hep.25827. Epub 2013 Jan 18.

3.

Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement.

Chen Z, Zhu Y, Ren Y, Tong Y, Hua X, Zhu F, Huang L, Liu Y, Luo Y, Lu W, Zhao P, Qi Z.

PLoS One. 2011 Apr 19;6(4):e18933. doi: 10.1371/journal.pone.0018933.

4.
5.

Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection.

Crotta S, Brazzoli M, Piccioli D, Valiante NM, Wack A.

J Hepatol. 2010 Feb;52(2):183-90. doi: 10.1016/j.jhep.2009.11.003. Epub 2009 Dec 16.

PMID:
20015567
6.

The hepatitis C envelope 2 protein inhibits LFA-1-transduced protein kinase C signaling for T-lymphocyte migration.

Volkov Y, Long A, Freeley M, Golden-Mason L, O'Farrelly C, Murphy A, Kelleher D.

Gastroenterology. 2006 Feb;130(2):482-92.

PMID:
16472601
7.

Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.

McKeating JA, Zhang LQ, Logvinoff C, Flint M, Zhang J, Yu J, Butera D, Ho DD, Dustin LB, Rice CM, Balfe P.

J Virol. 2004 Aug;78(16):8496-505.

8.

T cell costimulation by the hepatitis C virus envelope protein E2 binding to CD81 is mediated by Lck.

Soldaini E, Wack A, D'Oro U, Nuti S, Ulivieri C, Baldari CT, Abrignani S.

Eur J Immunol. 2003 Feb;33(2):455-64.

9.

Hepatitis C virus entry and the tetraspanin CD81.

Farquhar MJ, Harris HJ, McKeating JA.

Biochem Soc Trans. 2011 Apr;39(2):532-6. doi: 10.1042/BST0390532. Review.

PMID:
21428934
11.

Cross-linking of CD81 by HCV-E2 protein inhibits human intrahepatic plasmacytoid dendritic cells response to CpG-ODN.

Tu Z, Zhang P, Li H, Niu J, Jin X, Su L.

Cell Immunol. 2013 Jul-Aug;284(1-2):98-103. doi: 10.1016/j.cellimm.2013.07.012. Epub 2013 Aug 2.

12.

Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells.

Marukian S, Jones CT, Andrus L, Evans MJ, Ritola KD, Charles ED, Rice CM, Dustin LB.

Hepatology. 2008 Dec;48(6):1843-50. doi: 10.1002/hep.22550.

13.

Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.

Nattermann J, Zimmermann H, Iwan A, von Lilienfeld-Toal M, Leifeld L, Nischalke HD, Langhans B, Sauerbruch T, Spengler U.

Hepatology. 2006 Oct;44(4):945-54.

PMID:
17006905
14.

Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.

Nattermann J, Nischalke HD, Feldmann G, Ahlenstiel G, Sauerbruch T, Spengler U.

J Viral Hepat. 2004 Nov;11(6):519-26.

PMID:
15500552
15.

CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.

D'Agosto G, Trento E, Nosotti L, Bordignon V, Battista M, Prignano G, Pimpinelli F, Biolcati G, Macrì A, Palamara G, Miglioresi L, Morrone A, Di Carlo A, Cordiali-Fei P, Ensoli F.

J Biol Regul Homeost Agents. 2009 Jul-Sep;23(3):155-64.

PMID:
19828092
16.

Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells.

Wack A, Soldaini E, Tseng C, Nuti S, Klimpel G, Abrignani S.

Eur J Immunol. 2001 Jan;31(1):166-75.

17.

Innate and adaptive immune responses in HCV infections.

Heim MH, Thimme R.

J Hepatol. 2014 Nov;61(1 Suppl):S14-25. doi: 10.1016/j.jhep.2014.06.035. Epub 2014 Nov 3. Review.

18.

Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.

Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, Mosca M, Filliponi F, Brunetto RM, Bonino F, Abrignani S, Valiante NM.

J Exp Med. 2002 Jan 7;195(1):35-41.

19.

Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.

Triyatni M, Saunier B, Maruvada P, Davis AR, Ulianich L, Heller T, Patel A, Kohn LD, Liang TJ.

J Virol. 2002 Sep;76(18):9335-44.

20.

The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry.

Rocha-Perugini V, Lavie M, Delgrange D, Canton J, Pillez A, Potel J, Lecoeur C, Rubinstein E, Dubuisson J, Wychowski C, Cocquerel L.

BMC Microbiol. 2009 May 28;9:111. doi: 10.1186/1471-2180-9-111.

Supplemental Content

Support Center